FLO-PRED Drug Patent Profile
✉ Email this page to a colleague
When do Flo-pred patents expire, and when can generic versions of Flo-pred launch?
Flo-pred is a drug marketed by Taro and is included in one NDA. There is one patent protecting this drug.
This drug has eleven patent family members in nine countries.
The generic ingredient in FLO-PRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
DrugPatentWatch® Generic Entry Outlook for Flo-pred
Indicators of Generic Entry
Summary for FLO-PRED
International Patents: | 11 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 3,855 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for FLO-PRED |
What excipients (inactive ingredients) are in FLO-PRED? | FLO-PRED excipients list |
DailyMed Link: | FLO-PRED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FLO-PRED
US Patents and Regulatory Information for FLO-PRED
FLO-PRED is protected by two US patents.
Patents protecting FLO-PRED
Oral suspension of prednisolone acetate
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ASTHMA
Oral suspension of prednisolone acetate
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ALLERGIC REACTIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLO-PRED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLO-PRED
See the table below for patents covering FLO-PRED around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0614659 | ⤷ Try a Trial | |
Israel | 195759 | ⤷ Try a Trial | |
Japan | 2009079053 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |